Insufficient Radiofrequency Ablation Promotes the Growth of Non-small Cell Lung Cancer Cells Through PI3K/Akt/HIF-1α Signals
Overview
Authors
Affiliations
Accelerated progression of residual non-small cell lung cancer (NSCLC) after incomplete radiofrequency ablation (RFA) has frequently been reported. In this study, NSCLC cells A549, CCL-185, and H358 were treated using a water bath at 47°C for 5, 10, 15, 20, and 25 min gradually to establish the sublines A549-H, CCL-185-H, and H358-H, respectively. A549-H, CCL-185-H, and H358-H cells showed a significant increase in proliferation rate when compared with their corresponding parental cellsin vitro The expression of hypoxia-inducible factor-1α (HIF-1α) was obviously upregulated in both A549-H and CCL-185-H cells. Silencing of HIF-1α abolished the insufficient RFA-induced proliferation in A549-H and CCL-185-H cells. Furthermore, insufficient RFA treatment markedly elevated the phosphorylation of ERK1/2 and Akt, but not of p38 MAPK or JNK, in A549-H and CCL-185-H cells. The inhibitor of Akt, LY294002, but not the inhibitor of ERK1/2, PD98059, suppressed the upregulation of HIF-1α and the proliferation of A549-H and CCL-185-H cellsin vitro Thein vivoresults confirmed that insufficient RFA could trigger the tumor growth, upregulate the HIF-1α expression, and activate Akt in A549 xenograft tumors. Our data suggest that insufficient RFA can promote thein vitroandin vivogrowth of NSCLC via upregulating HIF-1α through the PI3K/Akt signals.
Dou Q, Grant A, Coutinto de Souza P, Moussa M, Nasser I, Ahmed M Radiol Imaging Cancer. 2024; 6(2):e230056.
PMID: 38426887 PMC: 10988335. DOI: 10.1148/rycan.230056.
Mueller L, Issa P, Hussein M, Elshazli R, Haidari M, Errami Y Gland Surg. 2024; 13(1):4-18.
PMID: 38323236 PMC: 10839696. DOI: 10.21037/gs-22-555.
Peng B, Ling X, Huang T, Wan J PLoS One. 2023; 18(11):e0294263.
PMID: 37948404 PMC: 10637661. DOI: 10.1371/journal.pone.0294263.
Cui R, Wang L, Zhang D, Zhang K, Dou J, Dong L Acta Pharm Sin B. 2022; 12(9):3475-3485.
PMID: 36176908 PMC: 9513490. DOI: 10.1016/j.apsb.2022.05.026.
[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors].
Liu B Zhongguo Fei Ai Za Zhi. 2022; 25(4):266-271.
PMID: 35477191 PMC: 9051299. DOI: 10.3779/j.issn.1009-3419.2022.102.09.